Targeted Regulation of PI3K/Akt/mTOR/NF-κB Signaling by Indole Compounds and their Derivatives: Mechanistic Details and Biological Implications for Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|13|7|1002-1013

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.13, Iss.7, 2013-09, pp. : 1002-1013

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 931-939

Spandidos Publications

Access to resources Recommend Favorite

Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 9, 2009-11 ,pp. : 1024-1038

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 1, 2016-01 ,pp. : 29-37

Bentham Science Publishers

Access to resources Recommend Favorite

βhydroxyisovalerylshikonin induces human cervical cancer cell apoptosis via PI3K/AKT/mTOR signaling

By            

Oncology Letters, Vol. 10, Iss. 6, 2015-01 ,pp. : 3434-3442

Spandidos Publications

Access to resources Recommend Favorite

Deregulation of PI3K/Akt/mTOR Signaling Pathways by Isoflavones and its Implication in Cancer Treatment

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 7, 2013-09 ,pp. : 1014-1024

Bentham Science Publishers

Access to resources Recommend Favorite